Share this
Adagio Therapeutics Raises $336 Million Series C for COVID-19 Treatment and Prevention
May 20, 2021
ArTara Agrees to Combine With Proteon
Transaction to create Nasdaq-listed rare and specialty disease therapeutic company • September 27, 2019
Therachon Agrees to Sell to Pfizer for Up to $810 Million
May 21, 2019
Aquestive – $74 Million IPO
September 12, 2018
Agilis Biotherapeutics Sells to PTC for $200 Million
Combination expands gene therapy programs for treatment of rare diseases • July 30, 2018
NEA Leads $50 Million Series C for Trevi Therapeutics
September 1, 2017
Cooley Enhances Corporate Life Sciences Capabilities
Boston office grows as 10th anniversary of New England launch approaches • March 2, 2017